-
STAT News – Biotech6 months agoSTAT+: ACIP conflict is test of Trump’s support for RFK Jr.’s vaccine policy overhaul
WASHINGTON — Federal health officials are weighing how to respond to a court ruling that stalled major parts of health secretary Robert F. Kennedy Jr.’s vaccine...
-
STAT News – Biotech6 months agoSTAT+: Up and down the ladder: The latest comings and goings
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send...
-
STAT News – Biotech6 months agoA conversation with the ‘godfather’ of biotech
On this week’s episode of “The Readout LOUD,” we bring you a special conversation with Stelios Papadopolous, also know as the “godfather” of biotech. He sat...
-
STAT News – Biotech6 months agoSTAT+: Pharmalittle: We’re reading about TrumpRx expectations, a high-dose version of Wegovy, and more
And so, another working week will soon come to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to...
-
STAT News – Biotech6 months agoSTAT+: U.K. to take another look at cost-effectiveness of Alzheimer’s drugs
LONDON — U.K. health officials on Friday said they had reopened a review of two new Alzheimer’s therapies after previously finding they did not provide good...
-
STAT News – Biotech6 months agoTobacco could get a boost from the farm bill. How does that square with MAHA?
The 2026 farm bill now working its way through Congress contains a number of provisions at odds with the Make America Healthy Again movement, particularly when...
-
STAT News – Biotech6 months agoOpinion: Congress must fix the No Surprises Act before it bankrupts patients and employers
Five years ago, President Trump delivered a historic victory for American patients when he signed the No Surprises Act (NSA) into law. The promise of this...
-
STAT News – Biotech6 months agoOpinion: How OB-GYNs like me are increasingly able to treat pain from IUDs and other gynecologic procedures
In recent years, a growing outcry has drawn long-overdue attention to a difficult truth: girls’ and women’s pain has too often been dismissed and undertreated in...
-
STAT News – Biotech6 months agoSTAT+: A family’s giving to the Broad Institute’s research tops $1 billion
The Broad Institute of MIT and Harvard is poised to receive a massive injection of cash to fund breakthroughs in the understanding and treatment of bipolar disorder and...
-
STAT News – Biotech6 months agoSTAT+: Novartis picks up experimental breast cancer therapy for $2B
LONDON — Novartis said Friday it was buying an experimental breast cancer drug from Delaware-based Synnovation Therapeutics for $2 billion upfront. The deal includes includes up...
Psychedelic therapies ride wave of public favor into FDA hearing
After a brief storm of political headwinds, mRNA is back with strong momentum
STAT+: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
